Practice
Use of biologics in a patient with rheumatoid arthritis refractory to methotrexate
Jasvinder A. Singh
CMAJ June 11, 2013 185 (9) 793-795; DOI: https://doi.org/10.1503/cmaj.121607
Jasvinder A. Singh
From the Medicine Service and the Center for Surgical and Medical Acute care Research and Transitions (C-SMART), Birmingham VA Medical Center, Birmingham, Ala.; the Department of Medicine at the School of Medicine, University of Alabama, Birmingham, Ala.; and the Department of Orthopedic Surgery, Mayo Clinic College of Medicine, Rochester, Minn.
MBBS MPH![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article Figures & Tables
There are no figures or tables available.
In this issue
Article tools
Respond to this article
Use of biologics in a patient with rheumatoid arthritis refractory to methotrexate
Jasvinder A. Singh
CMAJ Jun 2013, 185 (9) 793-795; DOI: 10.1503/cmaj.121607
Jump to section
- Article
- What are this patient’s treatment options?
- What adverse effects can occur with biologics?
- Given the increased risk of infection, what vaccinations should be considered?
- What about screening for tuberculosis?
- What precautions should this patient follow with biologics?
- The case revisited
- Acknowledgement
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics